Colorectal cancer patients with high ACTA2 expression have a shorter disease-free survival and ACTA2 expression is a significant prognostic factor comparable to lymph node metastasis [16, 17]. The gene discussed is ACTA2; the disease is metastatic malignant neoplasm in the lymph nodes.